Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 11 Cancer Pain 11 Pain 9 Pain, Postoperative 5 Agnosia 5 Colorectal Neoplasms 3 Colonic Neoplasms 3 Neoplastic Cells, Circulating 2 Neoplasm Metastasis 2 Mucositis 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia, Biphenotypic, Acute 2 Inflammation 2 Head and Neck Neoplasms 2 Chronic Pain 2 Breakthrough Pain 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thrombocythemia, Essential 1 Supratentorial Neoplasms 1 Stomach Neoplasms 1 Signs and Symptoms 1 Sezary Syndrome 1 Reperfusion Injury 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

soybean oil, phospholipid emulsion 1 blinatumomab 1 Stents 1 Radiotherapy, Conformal 1 Passive Cutaneous Anaphylaxis 1 Nephrotomy 1 Nephrostomy, Percutaneous 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Morphine 1 ClinOleic 1 Bupivacaine 1 Analgesia, Patient-Controlled 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Bites and Stings × Morphine × Clear all

NCT03165383 2017-05-24

TAP

Rajiv Gandhi Cancer Institute & Research Center, India

Phase NA Completed

Bites and Stings

Data powered by HemOnc (CC BY 4.0) Colophon ⚡